NASDAQ | ETF
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of health care companies.
The manager defines health care companies as companies engaged in health care innovations, such as developing new and effective therapies; pharmaceuticals; biotechnology; life sciences tools and services; managed health care; and/or health care equipment, supplies, providers, services, distributors, and facilities.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 13.76% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 7.56% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 4.54% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.93% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.74% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 3.68% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.66% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.21% |
| BDX | Becton Dickinson and Company | Healthcare | Medical Instruments & Supplies | 2.73% |
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.42% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 2.29% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.92% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.80% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 1.71% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 1.52% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 1.50% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 1.48% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.47% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.44% |
| DYN | Dyne Therapeutics Inc | Healthcare | Biotechnology | 1.39% |